Proto Labs(PRLB) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Fourth quarter revenue reached a record $136.5 million, up 11% year-over-year in constant currencies, marking the first sequential revenue growth from Q3 to Q4 since 2017 [18] - Full-year revenue for 2025 was a record $533.1 million, up 5.7% in constant currencies [20] - Non-GAAP gross margin for the fourth quarter was 44.8%, an increase of 140 basis points year-over-year [19] - Non-GAAP earnings per share for the fourth quarter were $0.44, up $0.06 year-over-year [19] Business Line Data and Key Metrics Changes - CNC revenue in the U.S. grew 35% in the fourth quarter and 16.7% year-over-year for 2025, driven by strong demand in drones, satellites, and rockets [18][20] - Injection molding revenue declined 1.9% in 2025, impacted by weakness in medical device demand [20] - 3D printing revenue declined 4.7% year-over-year, although metal 3D printing showed strength with double-digit growth [21] Market Data and Key Metrics Changes - U.S. revenue grew 9.1% year-over-year, while European revenue declined 7% in constant currencies [20] - The company noted strong momentum in high-growth markets such as aerospace, defense, and data centers [5][6] Company Strategy and Development Direction - The company aims to serve customers across the entire life cycle of a part, from prototype through production, focusing on four strategic pillars: elevate customer experience, accelerate innovation, expand production, and drive operational efficiency [7][11] - The establishment of a global capability center in India is intended to enhance innovation and digital capabilities [13] - The company plans to implement new go-to-market strategies in Europe to stabilize margins and reset the cost base for growth [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in entering 2026 from a position of strength, expecting a year of transformation and growth [11][17] - The company anticipates full-year 2026 revenue growth of 6%-8% and aims for sustained double-digit revenue growth in the long term [24][17] Other Important Information - The company generated $74.5 million in cash from operations in 2025 and returned $43 million to shareholders through repurchases [23] - The company has no debt and had $142.4 million in cash and investments on its balance sheet as of December 31, 2025 [23] Q&A Session Summary Question: Insights on Q4 performance and sequential growth - Management noted that Q4 saw good order volumes, but January started with a more normalized, softer order rate [29][30] Question: Details on end markets and growth areas - Management confirmed strong growth in innovation-led markets such as aerospace and defense, positioning the company well for future opportunities [32] Question: Strategic initiatives and their timelines - Management indicated that the current year is focused on transformation, with results expected to accelerate in the coming years [34] Question: Unique developer performance and revenue per contact - Management acknowledged a focus on increasing revenue per contact, with a 23% increase in Q4 [41] Question: Injection molding business visibility and growth potential - Management highlighted the importance of ISO certification for expanding production capabilities in injection molding, currently in pilot with two medical device manufacturers [52] Question: India capability center's focus - The center in India aims to leverage technical talent to support global business and innovation initiatives [56]